Bradley Pharma Gets an Offer

Bradley Pharmaceuticals Inc. (NYSE: BDY) said that it has received a $21.50 per share buyout offer led by company founder, president and CEO Daniel Glassman. The proposal letter also says that One Equity Partners has committed to provide an undisclosed amount of equity, while Credit Suisse Securities would underwrite the leveraged financing. Bradley said that it has formed a special committee of independent directors to consider the proposal, and other strategic alternatives.